التفاصيل البيبلوغرافية
العنوان: |
COVID-19 and bone health |
المؤلفون: |
C.-L. Hu, M.-J. Zheng, X.-X. He, D.-C. Liu, Z.-Q. Jin, W.-H. Xu, P.-Y. Lin, J.-W. Cheng, Q.-G. Wei |
المصدر: |
European Review for Medical and Pharmacological Sciences, Vol 27 (2023) |
بيانات النشر: |
Verduci Editore |
سنة النشر: |
2023 |
المجموعة: |
Directory of Open Access Journals: DOAJ Articles |
مصطلحات موضوعية: |
Therapeutics. Pharmacology, RM1-950 |
الوصف: |
A few patients who have recovered from COVID-19 develop persistent or new symptoms that last for weeks or months; this is called “long COVID” or “post-COVID-19 syndrome.” Over time, awareness of the short- and long-term consequences of COVID-19 has increased. The pulmonary consequences are now fairly well established, but little is known about the extrapulmonary system of COVID-19, particularly its effects on bones. Current evidence and reports indicate a direct relationship between SARS-CoV-2 infection and bone health, with SARS-CoV-2 having a significant negative effect on bone health. In this review, we analyzed the impact of SARS-CoV-2 infection on bone health and assessed the impact of COVID-19 on the diagnosis and treatment of osteoporosis. |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
English |
تدمد: |
1128-3602 |
Relation: |
https://www.europeanreview.org/wp/wp-content/uploads/3191-3200.pdf; https://doaj.org/toc/1128-3602; https://doaj.org/article/f9d64958c0304f289a0f2b9ca9e0ee19 |
الاتاحة: |
https://doaj.org/article/f9d64958c0304f289a0f2b9ca9e0ee19 |
رقم الانضمام: |
edsbas.F5018039 |
قاعدة البيانات: |
BASE |